Pharmacology
All Targets
7-TM Receptors
Ion Channels
Nuclear Receptors
Enzyme-Linked Receptors
Transporters
Enzymes
Other Pharmacology
Cellular Processes
Angiogenesis
Apoptosis
Cell Cycle
Cell Metabolism
Cytoskeleton & Motor Proteins
ECM & Adhesion Molecules
Signal Transduction
Stem Cells
Product Type
All Products
New Products
Small Molecules
Peptides
Antibodies
Jena Bioscience
Controlled Substances
Toxins
Caged Compounds
Fluorescent Probes
Screening Libraries
Ligand Sets
Other Product Types
Research Area
Cancer
Cardiovascular Disease
Endocrinology
Immunology
Metabolic Disease
Neurological Disease
Pain & Inflammation
Respiratory Disease
Home »
Pharmacology » Ion Channels » Ligand-gated Ion Channels » GABAA and GABAC Receptors » GABAA Receptors » Bretazenil
BretazenilCat No. 3568 |
Price and Availability |
|
Alternative Name: Ro 16-6028 Chemical Name: (13aS)-8-Bromo-11,12,13,13a-tetrahydro-9-oxo-9H-imidazo [1,5-a]pyrrolo[2,1-c][1,4]benzodiazepine-1-carboxylic acid 1,1-dimethylethyl ester |
|
Biological Activity
Partial agonist at the GABAA benzodiazepine site (EC50 = 10 nM at α1β1γ2 receptors). Displays anticonvulsive activity in vivo.Technical Data
M.Wt:418.28
Formula:C19H20BrN3O3
Solubility:Soluble to 100 mM in DMSO and to 100 mM in ethanol
Purity: >98 %
Storage:Desiccate at +4°C
CAS No:[84379-13-5]
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis and MSDS.
Resources
Certificate of Analysis / MSDS
Certificate of Analysis: View current batch
Material Safety Data Sheet: View current batch
References
Puia et al (1992) Molecular mechanisms of the partial allosteric modulatory effects of bretazenil at g-aminobutyric acid type A receptor. Proc.Natl.Acad.Sci. USA Neurobiology 89 3620. Rundfeldt et al (1995) Anticonvulsant tolerance and withdrawal characteristics of benzodiazepine receptor ligands in different seizure models in mice. Comparison of diazepam, bretazenil and abecarnil. J.Pharmacol.Exp.Ther. 275 693. Munro et al (2008) Comparison of the novel subtype-selective GABAA receptor-positive allosteric modulator NS11394 [3'-[5-(1-hydroxy-1-methyl-ethyl)-benzoimidazol-1-yl]-biphenyl-2-carbonitrile] with diazepam, zolpidem, bretazenil, and gaboxadol in rat models of inflammatory and neuropathic pain. J.Pharmacol.Exp.Ther. 327 969.If you know of a useful citation for this product please let us know.
Keywords: Bretazenil, benzodiazepines, partial, agonists, GABAA, receptors
Buy Now / Print Quote
Find multiple products by catalog number
New Products in this Area
MRK 016
α5-selective GABAA inverse agonist
TCS 1205Subtype-selective GABAA receptor agonist
Acamprosate calciumGABA agonist and glutamatergic modulator
Sign-up for new product e-alerts
New Product Guide
Highlights over 250 new products added in 2009/10. Request a copy or view PDF today.



